J Endocr Surg.  2019 Mar;19(1):25-33. 10.16956/jes.2019.19.1.25.

Analysis of Correlation between Thyroid Cancer Incidence and Socioeconomic Status Using 10-year Sample Cohort Database

• Yang SU
• Chang H
• Lim CY

• KMID: 2442158
• DOI: http://doi.org/10.16956/jes.2019.19.1.25

Abstract

PURPOSE
The authors hypothesized that increases in socioeconomic status (SES) have enabled patients to access medical services more frequently, resulting in the increased detection of small thyroid cancers. This retrospective cohort study was designed to analyze the correlation between thyroid cancer incidence and SES using a 10-year sample cohort database. METHOD: Sample cohort database between January 2004 and December 2013 with 1,000,000 cases for each year was enrolled in this study. Thyroid cancer incidence was analyzed by sex and by age. Public health insurance payment was used to reflect SES. The correlation between SES and thyroid cancer incidence was analyzed, and medical checkups done under government programs based on SES were analyzed.
RESULTS
When the results were considered according to SES, the high SES group showed a higher incidence of thyroid cancer than low SES group. Also, participation in government-supported health checkup programs was higher in the high SES group higher in the high SES group compared to low SES group.
CONCLUSION
SES and incidence of thyroid cancer have positive correlation.

Keyword

Thyroid cancer; Socioeconomic status; Health insurance; Database

MeSH Terms

Cohort Studies*
Government Programs
Humans
Incidence*
Insurance
Insurance, Health
Methods
Public Health
Retrospective Studies
Social Class*
Thyroid Gland*
Thyroid Neoplasms*

Reference

1. National Cancer Institute. Previous version: SEER sancer statistics review, 1975–2011 [Internet]. Bethesda (MD): National Cancer Institute;cited 2014 Oct 7. .

2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140:317–322.

3. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013; 347:f4706.

4. Pacini F, Castagna MG. Approach to and treatment of differentiated thyroid carcinoma. Med Clin North Am. 2012; 96:369–383.

5. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007; 177:1357–1361.

6. How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ. 2007; 177:1383–1384.

7. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995. Cancer Causes Control. 2000; 11:163–170.

8. Niu X, Roche LM, Pawlish KS, Henry KA. Cancer survival disparities by health insurance status. Cancer Med. 2013; 2:403–411.

9. Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013; 23:885–891.

10. Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention. Bethesda (MD): Oxford University Press;2006.

11. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008; 19:585–593.

12. Morris LG, Sikora AG, Myssiorek D, DeLacure MD. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol. 2008; 15:1169–1176.

13. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001; 93:745–750.

14. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003; 12:144–150.

15. Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987; 79:1–12.

16. National Cancer Information Center. Korea cancer registry statistics 2012 [Internet]. Goyang: National Cancer Information Center;2014. cited 2014 Dec 11. Available from: https://www.cancer.go.kr/lay1/S1T639C640/contents.do.

17. World Health Organization, International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence world-wide in 2012 [Internet]. Lyon: International Agency for Research on Cancer;2015. cited 2015 Aug 11. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.

18. Lee SY. Thyroid cancer screening. J Korean Med Assoc. 2015; 58:684–687.

19. Deen MH, Burke KM, Janitz A, Campbell J. Cancers of the thyroid: overview and statistics in the United States and Oklahoma. J Okla State Med Assoc. 2016; 109:333–338.

20. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Thyroid cancer facts and figures [Internet]. Bethesda (MD): National Cancer Institute;cited 2015 Sep 20. Available from: http://seer.cancer.gov/statfacts/html/thyro.html.

21. Hanley JP, Jackson E, Morrissey LA, Rizzo DM, Sprague BL, Sarkar IN, et al. Geospatial and temporal analysis of thyroid cancer incidence in a rural population. Thyroid. 2015; 25:812–822.

22. Semrad TJ, Semrad AM, Farwell DG, Chen Y, Cress R. Initial treatment patterns in younger adult patients with differentiated thyroid cancer in California. Thyroid. 2015; 25:509–513.

23. Reitzel LR, Nguyen N, Li N, Xu L, Regan SD, Sturgis EM. Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity. Thyroid. 2014; 24:556–567.

24. Corsten MJ, Hearn M, McDonald JT, Johnson-Obaseki S. Incidence of differentiated thyroid cancer in Canada by city of residence. J Otolaryngol Head Neck Surg. 2015; 44:36.

25. Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, Ba Y, et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid. 2009; 19:1061–1066.

26. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization;2000.

27. Robertson CT. Scaling cost-sharing to wages: how employers can reduce health spending and provide greater economic security. Yale J Health Policy Law Ethics. 2014; 14:239–295.

28. Nagar S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Grogan RH. Age of diagnosing physician impacts the incidence of thyroid cancer in a population. Cancer Causes Control. 2014; 25:1627–1634.

29. Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, et al. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 2014; 120:1345–1352.

30. Choi SW, Ryu SY, Han MA, Park J. The association between the socioeconomic status and thyroid cancer prevalence; based on the Korean National Health and Nutrition Examination Survey 2010–2011. J Korean Med Sci. 2013; 28:1734–1740.

31. Zheng T, Holford TR, Chen Y, Ma JZ, Flannery J, Liu W, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992. Int J Cancer. 1996; 67:504–509.